A study from the University of Tartu indicates that past prescription drug use can leave lasting traces on the gut microbiome, affecting microbial composition long after treatment ends.
Key facts
- •The study analyzed data from more than 2,500 participants in the Estonian Microbiome cohort.
- •Benzodiazepines showed associations with gut microbial patterns comparable to broad-spectrum antibiotics.
- •Researchers observed persistent microbiome effects linked to proton pump inhibitors, selective serotonin reuptake inhibitors, and specific antibiotics like macrolides.
- •The study found that individual drugs within the same class can have varying impacts on gut bacteria.
- •Follow-up samples confirmed that starting or stopping certain medications led to predictable shifts in gut microbial communities.
Researchers at the University of Tartu Institute of Genomics have found that prescription medications can influence the human gut microbiome for years after a patient stops taking them. By analyzing stool samples and prescription records from over 2,500 participants in the Estonian Biobank, the study revealed that many common drugs are linked to distinct microbial patterns. These findings suggest that a person's medical history is a significant factor in explaining individual differences in gut bacteria.
Lasting Effects Beyond Antibiotics
While antibiotics are known to disrupt gut bacteria, the study identified similar long-term effects from other drug classes, including antidepressants, beta-blockers, proton pump inhibitors, and benzodiazepines. Notably, benzodiazepines showed associations with the gut microbiome comparable to those of broad-spectrum antibiotics. These medications are frequently used to manage conditions such as high blood pressure, acid reflux, and anxiety.
Individual Drug Differences
The research highlights that medications within the same drug class do not necessarily impact the microbiome in the same way. For example, drugs like diazepam and alprazolam, which are used for similar conditions, demonstrated different levels of disruption to gut microbes. This suggests that future microbiome research may need to evaluate individual drugs separately rather than grouping them by class.
Implications for Clinical Research
Lead author Dr. Oliver Aasmets noted that while most studies focus on current medication use, past drug history is a surprisingly strong factor in individual microbiome variation. By accounting for this history, researchers may more accurately distinguish between microbiome changes caused by disease and those resulting from previous treatments. The study's authors hope these findings encourage clinicians to incorporate medication history when interpreting microbiome data.
Advertisement
This article was independently rewritten by ManyPress editorial AI from reporting originally published by ScienceDaily.
